B

Bionano Genomics
D

BNGO

0.22060
USD
0.00
(0.68%)
Market Open
Volume
37,678
EPS
-1
Div Yield
-
P/E
-0
Market Cap
22,499,705
OverviewSignalsIdeasNews
Related Instruments
    E
    EDIT
    -0.11500
    (-4.14%)
    2.66500 USD
    N
    NCSM
    -0.430
    (-1.85%)
    22.850 USD
    N
    NTRA
    -5.120
    (-3.39%)
    146.040 USD
    O
    OOMA
    0.030
    (0.22%)
    13.400 USD
    P
    PSTG
    -1.620
    (-3.25%)
    48.210 USD
    R
    RARE
    -2.865
    (-6.02%)
    44.745 USD
    R
    RGNX
    -1.51500
    (-13.60%)
    9.62500 USD
    V
    VEEV
    -16.200
    (-7.06%)
    213.260 USD
    More
News

Title: Bionano Genomics

Sector: Healthcare
Industry: Medical Instruments & Supplies
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.